Summary Three human cell lines derived from oro-pharyngeal squamous cell carcinomas of the head were investigated for bone-resorbing activity in vitro. Culture media from all three spontaneously produced a non-dialysable osteolytic factor with activity in three in vitro assays for interleukin 1 (ILl), viz. the lymphocyte activating factor (LAF) assay, stimulation of collagenase synthesis by articular chondrocytes, and stimulation of prostaglandin E2 synthesis by fibroblasts. Addition of anti-human ILl antibody to the culture media abolished all the bone-resorbing activity. Fractionation of the cell culture media by high performance liquid chromatography (HPLC) showed a single peak of activity in the chondrocyte assay with an apparent mol.wt of 15-17,000. This co-eluted with activity in a preparation of ILl from rat peritoneal macrophage cultures. These results indicate that ILI is responsible for the prostaglandinindependent bone resorbing activity synthesised by these cells in vitro, and may contribute to the bone destruction associated with the tumour.Bone resorption is a common feature of malignancy and can occur as a consequence of malignant cell growth in or adjacent to bone, or at sites distant from the malignant cells.The localised bone destruction frequently accompanying squamous cell carcinomas of the head and neck appears to be a two-stage process: the first phase characterised by osteoclastic resorption -presumably stimulated by tumour cell products, and a second phase of resorption by tumour cells themselves (Carter, 1985).Since the demonstration of soluble bone resorbing activity produced by mouse fibrosarcoma in vitro (Goldhaber, 1960), tissue culture has been an important tool for investigating the mechanisms of tumour-induced bone resorption. Prostaglandins (PG), notably PGE2, have been considered prime candidates as local mediators of osteolysis since they are potent stimulators of oesteoclastic bone resorption (Klein & Raisz, 1970) and are synthesised in increased amounts by several tumours in animals, including fibrosarcoma in mice (Tashjian et al., 1972) the VX2 carcinoma in rabbits (Voelkel et al., 1975), and in man, including carcinoma of the breast (Bennett et al., 1975);Dowsett et al., 1976), and squamous carcinomas of the head and neck (Tsao et al., 1981). PGs, however, are only one class of bone resorbing factor which may contribute to tumour osteolysis. Tsao et al. (1981Tsao et al. ( , 1983 showed that the bone resorption induced in culture by explants of squamous cell carcinoma of the head and neck was only partially inhibited by indomethacin. Indeed, carcinoma cell lines cultured from these tumours produced bone resorbing activity in the culture supernatants, but no detectable PGs. This indicated that the PGs synthesised by tumour explants may have originated from other cell types in the tumour, such as stromal fibroblasts.Another group of arachidonic acid metabolites, the lipoxygenase products, have also been shown to possess bone resorbing activity (Meghji et al., 1987). Porteder e...